GRIN Therapeutics' Pivotal Phase 3 Beeline Study Initiated in Europe

European initiation advances global registrational program for investigational radiprodil in GRIN-NDD; initiation augments sites already enrolling in the US and UK NEW YORK, May 4, 2026 /PRNewswire/ -- GRIN Therapeutics, Inc., a leader in the development of targeted, disease-specific...